Status:

RECRUITING

Insect vs Animal Protein for Building Muscle

Lead Sponsor:

University of Surrey

Collaborating Sponsors:

Aberystwyth University

Conditions:

Cricket Protein

Whey Protein

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This research is being carried out to investigate the potential of insects (crickets) as a sustainable protein source for supporting human muscle tissue by comparing cricket protein to a commonly used...

Detailed Description

Aims 1. To investigate the impact of insect (cricket) compared to animal (whey) protein on skeletal muscle anabolism (building and repair of muscle tissue) following a bout of resistance exercise. 2....

Eligibility Criteria

Inclusion

  • Adult males and females in general good health (aged 18+)
  • BMI between 18.5 and 35 kg/m2
  • Weight stable for 3 months (± 2 kg)
  • Volunteers must be able and willing to give informed written consent
  • Volunteers must be willing to provide blood and muscle tissue samples
  • Volunteers must have been resistance training at least 3x per week for a minimum of 2 years
  • Volunteers must be willing to follow a resistance training programme and consume a daily protein supplement for 12 weeks
  • Not allergic to local anaesthetic

Exclusion

  • Injury or illness that prevents the adherence to 12 weeks resistance training and protein supplementation
  • Those with metabolic conditions such as diabetes
  • Those taking nutritional ergogenic aids (e.g. creatine, beta-alanine, sodium bicarbonate, dietary nitrate etc.)
  • Those smoking, using nicotine products (e.g., e-cigarettes, patches) or not abstained from these activities for more than 6 months
  • Pregnant or lactating (those who become pregnant during this study must notify the researchers immediately and the participant will be removed)
  • Volunteers with a habitual caffeine intake \>400 mg/day (more than 5 cups standard coffee)
  • Drug or alcohol abuse in the last 2 years
  • Those who are taking performance enhancing drugs (PEDs) or have previously taken PEDs in the previous 10 years
  • Those who do not refrain from alcohol, caffeine containing drinks (e.g., coffee, coca cola, tea, Red Bull) and strenuous exercise 12 hours before the phase 1 visit
  • Those with food allergies
  • Those following weight loss diets
  • Those who are vegan, vegetarian or refrain from dairy/egg consumption

Key Trial Info

Start Date :

September 1 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

January 1 2027

Estimated Enrollment :

34 Patients enrolled

Trial Details

Trial ID

NCT07159919

Start Date

September 1 2025

End Date

January 1 2027

Last Update

September 8 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Surrey, Stag Hill Campus

Guildford, Surrey, United Kingdom, GU2 7XH